Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
5 Results Found
DEA and HHS Extend Waivers for Prescribing Controlled Substances Through Telemedicine
The Department of Health and Human Services (HHS) and Drug Enforcement Administration (DEA) Dec. 30 released a temporary rule extending for the fourth time waiver flexibilities for prescribing controlled substances via telemedicine.
AHA Statement to House E&C Health Subcommittee on Lowering Health Care Costs for All Americans
AHA Statement before the House Committee on Energy and Commerce
Health Subcommittee on “Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain”
House Subcommittee to Host Feb. 11 Hearing with Suppliers as Part of Series Focused on Health Care Affordability
The issue of affordability, including health care affordability, is front and center this year and will be part of this year's congressional and administration discussions, as well as the mid-term elections.
AHA, Other Groups: It’s Wrong to Tell Hospitals They ‘Are to’ Complete Drug Acquisition Cost Survey
Absent any statutory consequences for not completing the OPPS Drug Acquisition Cost Survey (ODACS), it is wrong for CMS to tell hospitals and health systems that they “are to” complete it.
CMS Issues Proposed Rule for CY 2027 Medicare Advantage, Prescription Drug Plans
The Centers for Medicare & Medicaid Services (CMS) Nov. 28 released its proposed Policy and Technical Changes to the Medicare Advantage (MA) Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program and Programs of All-Inclusive Care for the Elderly for Contract Year (CY) 2027.